A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells (original) (raw)
Single-colour flow cytometric assay to determine NK cell-mediated cytotoxicity and viability against non-adherent human tumor cells
Kim Jones
Biotechnology Letters, 2012
View PDFchevron_right
Neuroblastoma Cell Lines Are Refractory to Genotoxic Drug-Mediated Induction of Ligands for NK Cell-Activating Receptors
Irene Veneziani
Journal of Immunology Research
View PDFchevron_right
Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice
Vito Pistoia
Cancer Immunology, Immunotherapy, 2007
View PDFchevron_right
Growth and Activation of Natural Killer Cells Ex Vivo from Children with Neuroblastoma for Adoptive Cell Therapy
Michael Sheard
View PDFchevron_right
Antibody-dependent cellular cytotoxicity toward neuroblastoma enhanced by activated invariant NKT cells
慶太 照井
Cancer science, 2016
View PDFchevron_right
NK Cell-Based Glioblastoma Immunotherapy
Jose A. Costoya
Cancers
View PDFchevron_right
Development of immunomonitoring of antibody-dependent cellular cytotoxicity against neuroblastoma cells using whole blood
Holger Lode, Mark Cragg, Juliet Gray
Cancer Immunology, Immunotherapy, 2014
View PDFchevron_right
Rapid flow cytometry based cytotoxicity assay for evaluation of NK cell function
Kanjaksha Ghosh
Indian journal of experimental biology, 2014
View PDFchevron_right
Natural Killer Cell-Mediated Killing of Freshly Isolated Neuroblastoma Cells
Roberta Castriconi
Cancer Research, 2004
View PDFchevron_right
Characterizing the anti-tumor function of adoptively transferred NK cells in vivo
Phillip Darcy
Cancer Immunology, Immunotherapy, 2010
View PDFchevron_right
NKG2C+ NK Cells for Immunotherapy of Glioblastoma Multiforme
Monika Füssel
International Journal of Molecular Sciences
View PDFchevron_right
Natural Killer Cells to the Attack: Combination Therapy against Neuroblastoma
Itziar Astigarraga
Clinical Cancer Research, 2016
View PDFchevron_right
NK cells recognize and kill human glioblastoma cells with stem cell-like properties
Antonio Daga
Journal of immunology (Baltimore, Md. : 1950), 2009
View PDFchevron_right
IL-2-activated haploidentical NK cells restore NKG2D-mediated NK-cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA
Ruth Esser
European Journal of Immunology, 2010
View PDFchevron_right
Comparative study of NK cell-mediated cytotoxicity using radioactive and flow cytometric cytotoxicity assays
Bettina Langhans
Journal of Immunological Methods, 2005
View PDFchevron_right
Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical study
Gunnar Soderdahl
Immunotherapy, 2009
View PDFchevron_right
Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches
Vito Pistoia
Frontiers in Immunology, 2014
View PDFchevron_right
A novel enhanced green fluorescent protein (EGFP)-K562 flow cytometric method for measuring natural killer (NK) cell cytotoxic activity
Jiraporn Jaroenpool
Journal of Immunological Methods, 2003
View PDFchevron_right
Glioblastoma Stem-Like Cells Are More Susceptible Than Differentiated Cells to Natural Killer Cell Lysis Mediated Through Killer Immunoglobulin-Like Receptors–Human Leukocyte Antigen Ligand Mismatch and Activation Receptor–Ligand Interactions
Mohummad Aminur Rahman
2018
View PDFchevron_right
Standardized and flexible eight colour flow cytometry panels harmonized between different laboratories to study human NK cell phenotype and function
John Veluchamy
Scientific reports, 2017
View PDFchevron_right
Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis
Claudia Cantoni
Proceedings of the National Academy of Sciences, 2004
View PDFchevron_right
Membrane-bound TRAIL Supplements Natural Killer Cell Cytotoxicity Against Neuroblastoma Cells
Tsen-Yin Lin, Michael Sheard
View PDFchevron_right
NK Cell-Based Immunotherapy for Hematological Malignancies
Simona Sivori
Journal of Clinical Medicine, 2019
View PDFchevron_right